As reported in previous studies, enhanced Myd88 could not only evade apoptotic stimulation and promote cell-cycle progress but also confer tumor cells with strengthened abilities of proliferation, migration and invasion especially in HCC. The gene discussed is MYD88; the disease is hepatocellular carcinoma.